Salvianolic acid B as a potent nano‐agent for enhanced ALA‐PDT of oral cancer and leukoplakia cells
Oral Diseases · 2024
DOI: 10.1111/odi.14525 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, 2024. Verfasst von Ying Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Mucosal Diseases, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Photochemotherapy, Mouth Neoplasms, Photosensitizing Agents, Aminolevulinic Acid. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality, Shanghai Municipal Health Committee.
Abstract (Originalsprache)
Background
Photodynamic therapy (PDT) relies on the light activation of a photosensitizers to generate reactive oxygen species such as singlet oxygen, but its effect on cancer therapy is limited dramatically by hypoxia in the tumor microenvironment.
Objectives
To determine the potential of a nano‐photosensitizer loaded salvianolic acid B (SalB) and 5‐aminolevulinic acid (ALA) for enhancing the efficacy of PDT in oral squamous cell carcinoma Cal27 cells and leukoplakia Leuk1 cells.
Results
Singlet oxygen sensor green (SOSG) assay showed that nano‐SalB‐ALA generated higher levels of singlet oxygen, compared to nano‐SalB and nano‐ALA. Cellular uptake assay showed that nano‐SalB‐ALA effectively absorbed by Leuk1 cells. Importantly, cell counting kit‐8 and flow cytometry revealed that PDT with nano‐SalB‐ALA effectively inhibited the viability and induced the apoptosis of Cal27 and Leuk1 cells, respectively. Moreover, the tumor xenograft study revealed that PDT with nano‐SalB‐ALA had a stronger inhibitory effect on tumor growth of nude mice, compared to control groups.
Conclusions
The novel photosensitizer nano‐SalB‐ALA remarkably enhanced the efficacy of PDT by improving singlet oxygen production, inhibiting cell proliferation, promoting cell apoptosis, and suppressing tumor growth. These suggest PDT with nano‐SalB‐ALA could be a clinically significant and potent treatment for oral cancer and leukoplakia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral Mucosal Diseases, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- College of Stomatology, Shanghai Jiao Tong University, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology, Shanghai Research Institute of Stomato…
- Department of Oral and Maxillofacial-Head and Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
ORCID-Profile: Ying Zhang, Sai Ye, Zengtong Zhou, Wei Liu, Lan Wu
Förderung
- National Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality
- Shanghai Municipal Health Committee
- Shanghai Jiao Tong University School of Medicine
- Shanghai Municipal Health Commission
- School of Medicine, Shanghai Jiao Tong University
Zitieren
APA
Zhang, Y., Ye, S., Zhou, Y., Zhou, Z., Yao, Y., Liu, W., & Wu, L. (2024). Salvianolic acid B as a potent nano‐agent for enhanced ALA‐PDT of oral cancer and leukoplakia cells. Oral Diseases. https://doi.org/10.1111/odi.14525
Vancouver
Zhang Y, Ye S, Zhou Y, Zhou Z, Yao Y, Liu W, et al. Salvianolic acid B as a potent nano‐agent for enhanced ALA‐PDT of oral cancer and leukoplakia cells. Oral Diseases. 2024. doi:10.1111/odi.14525
BibTeX
@article{Zhang2024,
author = {Zhang, Ying and Ye, Sai and Zhou, Yongmei and Zhou, Zengtong and Yao, Yilin and Liu, Wei and Wu, Lan},
title = {Salvianolic acid B as a potent nano‐agent for enhanced ALA‐PDT of oral cancer and leukoplakia cells},
journal = {Oral Diseases},
year = {2024},
doi = {10.1111/odi.14525}
}
EUVIMED